TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive Senate Subcommittee Adds $98 Million to NCI’s FY 1984 Budget, Assuring Substantial Increase September 30, 1983
TCL Archive Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival September 28, 2012